Participate in our study

The CanTreatCOVID trial relies on volunteers, often referred to as participants, to help us better understand the effectiveness of medications for mild to moderate COVID-19. The study is open to adults aged 18 – 49 years with one or more chronic condition(s) or adults aged 50+ years who tested positive for COVID with symptoms starting within the last five days.

Email: info@cantreatcovid.org

Toll-free line: 1-888-888-3308

Recruitment in Ontario is now open.

The study is open to:

  • Adults aged 18-49 years with one or more chronic condition(s) listed below OR adults aged 50+ years
  • Who tested positive for COVID-19 with symptoms starting within the last five days

Individuals currently taking Paxlovid or hospitalized for COVID-19 are not eligible to participate.

Adults aged 18-49 years who tested positive for COVID must have at least one of the following chronic conditions to participate in the study:

  • Chronic respiratory disease (including COPD, cystic fibrosis and asthma requiring at least daily use of preventative and/or reliever medication)
  • Chronic heart or vascular disease
  • Chronic kidney disease
  • Chronic liver disease
  • Chronic neurological disease (including dementia, stroke, epilepsy)
  • Severe and profound learning disability
  • Down’s syndrome
  • Diabetes (Type 1 or Type 2)
  • Immunosuppression: primary (e.g. inherited immune disorders resulting from genetic mutations) or secondary due to disease or treatment (e.g. sickle cell, HIV, cancer, chemotherapy)
  • Solid organ, bone marrow and stem cell transplant recipients
  • Morbid obesity (BMI >35)
  • Severe mental illness
  • Care home resident

To learn more, use the form above or contact us at info@cantreatcovid.org or 1-888-888-3308.